Patient advocacy organizations like the Chordoma Foundation and SMARCB1 Hope play a crucial role in supporting patients with rare sinonasal and skull base tumors by providing resources, fostering research, and building community connections. Their efforts highlight the importance of collaboration between patients, clinicians, and researchers to improve outcomes and care.
